FNCH
Finch Therapeutics Group (FNCH)
$
00About Finch Therapeutics Group (FNCH)
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Details
Daily high
$15.60
Daily low
$15.00
Price at open
$15.50
52 Week High
$15.75
52 Week Low
$0.80
Market cap
24.1M
Dividend yield
0.00%
Volume
3,123
Avg. volume
2,815
P/E ratio
-1.70
Finch Therapeutics Group News
Details
Daily high
$15.60
Daily low
$15.00
Price at open
$15.50
52 Week High
$15.75
52 Week Low
$0.80
Market cap
24.1M
Dividend yield
0.00%
Volume
3,123
Avg. volume
2,815
P/E ratio
-1.70